Current topics on plasma lipoprotein, phospholipase A2, and leptin receptor of aquatic animals

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Variability of lipoprotein-associated phospholipase A2 measurements.

We read with interest the recent report in this journal by Khuseyinova and colleagues regarding the variability of serial lipoprotein-associated phospholipase A2 (Lp-PLA2) measurements in postmyocardial infarction patients (1). Because Lp-PLA2 plays a role in inflammation but, unlike other inflammatory proteins , is not an acute-phase reactant (2), nonspecificity issues associated with acute-ph...

متن کامل

Lipoprotein-associated Phospholipase A2: Effects of Low Density Lipoprotein Apheresis

In addition to hypercholesterolemia, chronic arterial inflammation has been shown to be strongly associated with atherosclerosis and cardiovascular disease (CVD) [1]. The accumulation and oxidation of LDL within the intima trigger inflammatory processes within the vessel wall. Certain markers of inflammation, such as C-reactive protein (CRP), soluble CD40 ligand (sCD40L), oxidized LDL, and lipo...

متن کامل

Effect of Cardiovascular Drugs on the Plasma Levels of Lipoprotein- Associated Phospholipase A2 (Lp-PLA2)

Several lines of evidence suggest that the lipoprotein-associated phospholipase A2 (Lp-PLA2) plays an important role in the pathogenesis of atherosclerotic disease. From a pathophysiological point of view the enzyme bound to apolipoprotein-B-containing lipoproteins (which corresponds to more than 90% of plasma enzymatic activity) may play a proatherogenic role since it generates lysophosphatidy...

متن کامل

Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.

OBJECTIVE Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a predictor for incident atherosclerotic disease. We investigated the effect of 3 hypolipidemic drugs that exert their action through different mechanisms on plasma and lipoprotein-associated Lp-PLA2 activity and mass. METHODS AND RESULTS In 50 patients with Type IIA dyslipidemia were administered rosuvastatin (10 mg daily), where...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: NIPPON SUISAN GAKKAISHI

سال: 2004

ISSN: 0021-5392,1349-998X

DOI: 10.2331/suisan.70.764